Flynn Sean C.
Known title: VP, General CounselCIK: 0001801993
Associated companies
Transaction History
| VCEL | ▲ Buy | Option Exercise | 15,000 | $244K | 6/26/2026 | View on chart |
| VCEL | ▼ Sell | Open Market | 15,000 | $685K | 6/26/2026 | View on chart |
| VCEL | ▼ Sell | Open Market | 15,000 | $603K | 6/18/2026 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 15,000 | $244K | 6/18/2026 | View on chart |
| VCEL | ▼ Sell | Open Market | 6,421 | $223K | 3/2/2026 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 15,000 | $244K | 3/2/2026 | View on chart |
| VCEL | ▼ Sell | Open Market | 15,000 | $530K | 3/2/2026 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 3,500 | $0 | 2/24/2026 | View on chart |
| VCEL | ▼ Sell | Tax Withholding | 1,553 | $59K | 2/24/2026 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 3,000 | $0 | 2/24/2026 | View on chart |
| VCEL | ▼ Sell | Tax Withholding | 1,331 | $51K | 2/24/2026 | View on chart |
| VCEL | ▼ Sell | Tax Withholding | 1,490 | $55K | 2/18/2026 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 2,325 | $0 | 2/18/2026 | View on chart |
| VCEL | ▼ Sell | Tax Withholding | 1,030 | $39K | 2/18/2026 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 3,000 | $0 | 2/18/2026 | View on chart |
| VCEL | ▼ Sell | Open Market | 1,669 | $87K | 2/25/2025 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 3,000 | $0 | 2/24/2025 | View on chart |
| VCEL | ▼ Sell | Tax Withholding | 1,331 | $70K | 2/24/2025 | View on chart |
| VCEL | ▼ Sell | Open Market | 3,835 | $220K | 2/20/2025 | View on chart |
| VCEL | ▼ Sell | Tax Withholding | 777 | $45K | 2/19/2025 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 1,750 | $0 | 2/19/2025 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 3,000 | $0 | 2/18/2025 | View on chart |
| VCEL | ▼ Sell | Tax Withholding | 1,431 | $82K | 2/18/2025 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 2,325 | $0 | 2/18/2025 | View on chart |
| VCEL | ▼ Sell | Tax Withholding | 1,032 | $59K | 2/18/2025 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 15,000 | $244K | 7/16/2024 | View on chart |
| VCEL | ▼ Sell | Open Market | 15,000 | $783K | 7/16/2024 | View on chart |
| VCEL | ▼ Sell | Open Market | 1,474 | $68K | 6/24/2024 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 1,474 | $24K | 6/24/2024 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 6,772 | $110K | 6/21/2024 | View on chart |
| VCEL | ▼ Sell | Open Market | 6,772 | $305K | 6/21/2024 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 6,754 | $110K | 6/20/2024 | View on chart |
| VCEL | ▼ Sell | Open Market | 6,754 | $304K | 6/20/2024 | View on chart |
| VCEL | ▼ Sell | Open Market | 8,115 | $368K | 3/8/2024 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 3,000 | $0 | 2/20/2024 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 2,325 | $0 | 2/20/2024 | View on chart |
| VCEL | ▼ Sell | Tax Withholding | 1,032 | $51K | 2/20/2024 | View on chart |
| VCEL | ▼ Sell | Tax Withholding | 1,441 | $71K | 2/20/2024 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 1,750 | $0 | 2/20/2024 | View on chart |
| VCEL | ▼ Sell | Tax Withholding | 777 | $38K | 2/20/2024 | View on chart |
| VCEL | ▼ Sell | Open Market | 106 | $4K | 12/14/2023 | View on chart |
| VCEL | ▼ Sell | Open Market | 1,432 | $49K | 12/13/2023 | View on chart |
| VCEL | ▼ Sell | Gift | 1,042 | $0 | 11/15/2023 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 1,750 | $0 | 2/19/2023 | View on chart |
| VCEL | ▼ Sell | Tax Withholding | 832 | $25K | 2/19/2023 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 2,325 | $0 | 2/18/2023 | View on chart |
| VCEL | ▼ Sell | Tax Withholding | 1,155 | $34K | 2/18/2023 | View on chart |
| VCEL | ▼ Sell | Tax Withholding | 869 | $30K | 2/19/2022 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 1,750 | $0 | 2/19/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Truist lowers Vericel price target to $52
Truist Securities maintained its positive stance on Vericel but reduced its price target to $52. This adjustment places the new target below the current average analyst estimate of $60.57. The move reflects a cautious outlook despite the firm's continued positive assessment of the company.
Truist lowers Vericel price target to $52. Truist Securities maintained its positive stance on Vericel but reduced its price target to $52. This adjustment places the new target below the current average analyst estimate of $60.57. The move reflects a cautious outlook despite the firm's continued positive assessment of the company.